Archive

Simple muscle ultrasound may detect early prediabetes

Written by Charlie King | 4 Jul 2025

A simple ultrasound of a patient’s thigh or shoulder muscle may detect insulin resistance before it progresses to type 2 diabetes or even prediabetes. In a study, Michigan… read more.

Amgen highlights 52-week weight loss data for MariTide and cardiovascular outcomes at ADA Scientific Sessions

Written by Charlie King | 19 Jun 2025

Amgen announced full results from Part 1 of the Phase II study for MariTide (maridebart cafraglutide, formerly AMG 133) in patients living with obesity, with and without Type… read more.

Primary care clinics can successfully use glucose monitors to help people with diabetes

Written by Charlie King | 18 Jun 2025

A new study from the University of Colorado Anschutz Medical Campus shows that primary care clinics can successfully help patients start using continuous glucose monitors (CGMs), which track blood sugar… read more.

Smartwatches may help control diabetes through exercise

Written by Charlie King | 6 Apr 2025

Wearable mobile health technology could help people with Type 2 Diabetes (T2D) to stick to exercise regimes that help them to keep the condition under control, a new… read more.

‘True food’ research database offers rankings for 50,000 processed foods

Written by Charlie King | 16 Jan 2025

The database, developed by researchers at Mass General Brigham and made available to the public, sheds light on the availability of processed foods at different grocery stores, highlighting… read more.

GLP-1 RA drugs effectively treat obesity in adults without diabetes

Written by Bruce Sylvester | 7 Jan 2025

A meta- analysis of studies evaluating the efficacy and safety of various glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for treating obesity in adults without diabetes, suggests… read more.

Combined health screening can detect liver damage in diabetic patients

Written by Gary Finnegan | 2 Jan 2025

New research from Karolinska Institutet in Sweden highlights the potential benefits of screening people with type 2 diabetes for liver damage at the same time as they undergo… read more.

Combined screening can detect liver damage in diabetes patients

Written by Charlie King | 20 Dec 2024

New research from Karolinska Institutet in Sweden highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening… read more.

Tirzepatide shows powerful diabetes-prevention effect in three-year trial

Written by Charlie King | 2 Dec 2024

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a… read more.

Study finds bariatric surgery declined with rise in GLP-1 drugs to treat obesity

Written by Charlie King | 28 Nov 2024

A new study by researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with researchers at Harvard T.H. Chan School of Public… read more.

Diabetes drug shows promise in protecting kidneys

Written by Charlie King | 22 Nov 2024

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An… read more.

Long-term efficacy and safety profile of Eylea 8 mg with extended dosing intervals in diabetic macular edema confirmed at three years – Bayer

Written by Charlie King | 28 Oct 2024

Bayer and its collaboration partner Regeneron presented results from the open-label extension study of the clinical trial PHOTON in patients with diabetic macular edema (DME) at three years,… read more.

« Previous 1 2 3 4 … 37 Next »

Archive

Subscribe for our mailing list

Follow Us